Disclosure 0000875320-26-000272-1

SEC FORM 4

$0.00

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Acquisition (code A) of 8,682 shares at $0 per share.

Reporting Person van Grunsven Jasper · Officer Title EVP, CP and NPPO · Transaction Code A

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0000875320-26-000272 · filed 2026-09-10 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "VERTEX PHARMACEUTICALS INC / MA (VRTX)." Disclosed 2026-09-10. https://desqlong.com/cards/0000875320-26-000272-1 (retrieved 2026-09-26).